● Company · Biotechnology
Familiar Therapeutics
Veterinary biotechnology company translating clinically researched human medicines into therapies for serious diseases in dogs and cats.
Total raised
$5.0M
across 1 round
Valuation
$33.3M
estimated (modeled)
Investors
3
unique backers
Employees
—
reported
Cadence
—
single round only
Funding history
Latest: $5.0M Seed on Oct 21, 2026.
1 round · $5.0M
Oct 21, 2026
$5.0M
Seed · latest
Official company release dated October 21; angel participants not individually identified. Veterinary biotechnology company translating clinically researched human medicines into therapies for serious diseases in dogs and cats.
BreakTHRU · Icehouse Ventures · Pioneer Fund
Detected tech stack
From public scans of familiartx.com.
Other
Near peers
Companies at a comparable stage and sector.
Undisclosed stage · Biotechnology,Drug Development,Neuroscience · Sep 22, 2026
Growth Investment · Biotechnology,CDMO,Pharmaceutical Manufacturing · Sep 29, 2026
Seed · HealthTech,Biotechnology,Healthcare Data,Artificial Intelligence · Oct 22, 2026